VBIO

Valion Bio Inc

• TipRanks·6d ago

  Valion Bio Issues Milestone Preferred Stock to Investors

• TipRanks·07/22 11:50

  Valion Bio’s regulatory dossier for Entolimod accepted for review in Ukraine

• PR Newswire·07/20 17:28

  World-Premier Cancer Center Sheba Medical Center Selects Entolimod for Clinical Trial, Potentially Expanding Valion Bio into the Multi-Billion-Dollar Neutropenia Market

• TipRanks·07/17 20:10

  Valion Bio files to sell 29.41M shares of common stock, warrants

• Dow Jones·07/17 20:05

  *Valion Bio Offering Up to 29.4M Shrs and Up to 29.4M Common Warrants

• TipRanks·07/15 08:07

  Valion Bio advances Entolimod platform and manufacturing scale-up

• TipRanks·07/14 11:55

  Valion Bio reports continued development of Entolimod program

• PR Newswire·07/14 11:45

  Valion Bio Advances Integrated Biodefense and Immunology Platform Through Continued Government Engagement, Domestic Manufacturing and Oncology Expansion

• TipRanks·06/18 13:55

  Valion Bio Completes New Preferred Stock Financing Round

• PR Newswire·06/11 11:45

  Valion Bio (NASDAQ: VBIO) Confirms U.S. House Armed Services Committee Initiative to Address Urgent Need for Radiation /Nuclear Countermeasures

• TipRanks·06/03 13:40

  Valion Bio Shareholders Approve Director, Auditor and Equity Plan

• PR Newswire·05/19 20:38

  VALION BIO BRIEFS SENIOR DEPARTMENT OF WAR AND BARDA OFFICIALS IN JOINT ENGAGEMENT ON ENTOLIMOD FOR ACUTE RADIATION SYNDROME

• Seeking Alpha·05/15 13:08

  Tivic Health Systems reports Q1 results

• TipRanks·05/14 22:33

  Valion Bio Reports Q1 Results, Advances Entolimod Platform

• TipRanks·05/14 22:26

  Valion Bio’s Velocity Bioworks licenses LarmorBio’s BioScan-NMR platform